TREM2 and diabetes mellitus: The present study demonstrated that TREM2 modulates high glucose-induced microglial inflammation via the NLRP3 signaling pathway providing evidence for the study of chronic neuroinflammation and the immunometabolic response in diabetes neuroinflammation.